Table 1.

Subject disposition (Randomized set)

	Midostaurin (n = 80)	Moxifloxacin (n = 44)	Placebo (n = 68)
Participants, no. (%)
Completed	56 (70.0)	44 (100.0)	66 (97.1)
ECG set	54 (67.5)	43 (97.7)	64 (94.1)
Discontinued	24 (30.0)	0 (0.0)	2 (2.9)
Main cause of discontinuation
Death	0 (0.0)	0 (0.0)	0 (0.0)
Adverse event(s)	19 (23.8)	0 (0.0)	0 (0.0)
Abnormal test procedure	2 (2.5)	0 (0.0)	0 (0.0)
Withdrew consent	2 (2.5)	0 (0.0)	1 (1.5)
Protocol violation(s)	1 (1.3)	0 (0.0)	0 (0.0)
Administrative reasons	0 (0.0)	0 (0.0)	1 (1.5)

ECG, electrocardiogram